{"id":"W3216319709","doi":"10.1016/j.ejca.2021.09.043","title":"Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Docetaxel; Medicine; Prostate cancer; Chemotherapy; Oncology; Internal medicine; Nivolumab; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007734081,0.000810957,0.001271058,0.0002007025,0.0002666558,0.001031788,0.0005025472,0.0005995536,0.002087574],"category_scores_gemma":[0.001041545,0.0002796025,0.001509151,0.0002656595,0.0004719959,0.0006982231,0.0002155588,0.002312083,0.0004460385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009276471,"about_ca_system_score_gemma":0.0008665798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002188013,"about_ca_topic_score_gemma":0.008547414,"domain_scores_codex":[0.9997506,0.000119333,0.00001129678,0.00004427565,0.00002553255,0.00004897116],"domain_scores_gemma":[0.9996594,0.00009344875,0.00007462152,0.00002402873,0.00002163078,0.0001268399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7298542,0.009614909,0.01053574,0.002178246,0.00541948,0.0001595039,0.0002572717,0.005678648,0.007733158,0.0005554474,0.009760894,0.2182525],"study_design_scores_gemma":[0.7842823,0.1401944,0.04980416,0.0004264227,0.00506412,0.0005196046,0.0002918064,0.004114243,0.00216659,0.001422981,0.01160306,0.00011016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981073,0.01328041,0.0002364745,0.0008291732,0.0003962035,0.000346866,0.0008560893,0.00007032016,0.002911398],"genre_scores_gemma":[0.9900964,0.004754618,0.0004283688,0.0008139119,0.000173764,0.0001892758,0.001245963,0.00002341676,0.002274322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002188013,"threshold_uncertainty_score":0.006983578,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03304210653768105,"score_gpt":0.3307903809683758,"score_spread":0.2977482744306947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}